InvestorsObserver
×
News Home

Should You Add Unicycive Therapeutics Inc (UNCY) Stock to Your Portfolio Tuesday?

Tuesday, March 21, 2023 10:36 AM | InvestorsObserver Analysts

Mentioned in this article

Should You Add Unicycive Therapeutics Inc (UNCY) Stock to Your Portfolio Tuesday?

Unicycive Therapeutics Inc (UNCY) is around the top of the Healthcare sector according to InvestorsObserver. UNCY received an overall rating of 95, which means that it scores higher than 95% of stocks. Additionally, Unicycive Therapeutics Inc scored a 99 in the Healthcare sector, ranking it higher than 99% of stocks in that sector.

Overall Score - 95
UNCY has an Overall Score of 95. Find out what this means to you and get the rest of the rankings on UNCY!

What do These Ratings Mean?

Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. *Investors Observer* makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts. Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Unicycive Therapeutics Inc Stock Today?

Unicycive Therapeutics Inc (UNCY) stock is trading at $2.34 as of 10:34 AM on Tuesday, Mar 21, an increase of $0.15, or 6.85% from the previous closing price of $2.19. The stock has traded between $2.18 and $2.49 so far today. Volume today is less active than usual. So far 553,443 shares have traded compared to average volume of 12,016,800 shares. Click Here to get the full Stock Report for Unicycive Therapeutics Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App